These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prolactin stimulating effects of amoxapine and loxapine in psychiatric patients. Robertson AG; Berry R; Meltzer HY Psychopharmacology (Berl); 1982; 78(3):287-92. PubMed ID: 6818584 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of amoxapine in psychotic depression. Anton RF; Sexauer JD Am J Psychiatry; 1983 Oct; 140(10):1344-7. PubMed ID: 6624968 [TBL] [Abstract][Full Text] [Related]
5. Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites. Burch EA; Goldschmidt TJ South Med J; 1983 Aug; 76(8):991-5. PubMed ID: 6879296 [TBL] [Abstract][Full Text] [Related]
6. A critical appraisal of amoxapine. Smith RS; Ayd FJ J Clin Psychiatry; 1981 Jun; 42(6):238-42. PubMed ID: 7240104 [TBL] [Abstract][Full Text] [Related]
7. Amoxapine: a review of its pharmacology and efficacy in depressed states. Jue SG; Dawson GW; Brogden RN Drugs; 1982 Jul; 24(1):1-23. PubMed ID: 7049659 [TBL] [Abstract][Full Text] [Related]
8. Amoxapine and amitriptyline in the outpatient treatment of endogenous depression. Donlon PT; Biertuemphel H; Willenbring M J Clin Psychiatry; 1981 Jan; 42(1):11-5. PubMed ID: 7007357 [TBL] [Abstract][Full Text] [Related]
9. Amoxapine--an antidepressant with some neuroleptic properties? A review of its chemistry, animal pharmacology and toxicology, human pharmacology, and clinical efficacy. Lydiard RB; Gelenberg AJ Pharmacotherapy; 1981; 1(3):163-78. PubMed ID: 6152816 [TBL] [Abstract][Full Text] [Related]
10. Suppression of tardive dyskinesia with amoxapine: case report. D'Mello DA; Nasrallah HA J Clin Psychiatry; 1986 Mar; 47(3):148. PubMed ID: 3949726 [TBL] [Abstract][Full Text] [Related]
11. Effect of amoxapine on speech in a patient with Huntington's disease. Moldawsky RJ Am J Psychiatry; 1984 Jan; 141(1):150. PubMed ID: 6229184 [No Abstract] [Full Text] [Related]
12. Tolerance to amoxapine antidepressant effects. Zetin M; Aden G; Moldawsky R Clin Ther; 1983; 5(6):638-43. PubMed ID: 6627290 [TBL] [Abstract][Full Text] [Related]
13. Amoxapine in psychotic-delusional depression. Ragheb M; Ban TA Am J Psychiatry; 1984 Oct; 141(10):1312-3. PubMed ID: 6486282 [No Abstract] [Full Text] [Related]
14. Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients. Gelenberg AJ; Wojcik JD; Lydiard RB; McCormick MG; Falk WE; Hicks RH; Curren FC; Cohen BM J Clin Psychiatry; 1984 Feb; 45(2):54-56, 57-9. PubMed ID: 6363397 [TBL] [Abstract][Full Text] [Related]
16. Case report of withdrawal dyskinesia associated with amoxapine. Lesser I Am J Psychiatry; 1983 Oct; 140(10):1358-9. PubMed ID: 6624971 [TBL] [Abstract][Full Text] [Related]
17. Amoxapine for the treatment of psychotically depressed subjects. A pilot study. Falk WE; Gelenberg AJ; Wojcik JD J Nerv Ment Dis; 1985 Feb; 173(2):90-3. PubMed ID: 3968551 [TBL] [Abstract][Full Text] [Related]
18. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Anton RF; Burch EA Am J Psychiatry; 1990 Sep; 147(9):1203-8. PubMed ID: 2201223 [TBL] [Abstract][Full Text] [Related]
19. Amoxapine: neuroleptic as well as antidepressant? Cohen BM; Harris PQ; Altesman RI; Cole JO Am J Psychiatry; 1982 Sep; 139(9):1165-7. PubMed ID: 6126130 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the onset of action and therapeutic efficacy of amoxapine and amitriptyline. Hekimian LJ; Friedhoff AJ; Deever E J Clin Psychiatry; 1978 Jul; 39(7):633-7. PubMed ID: 681295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]